Oncofertility preservation: FIGO good clinical practice guidance

Affiliations

¹ Department of Obstetrics and Gynecology, Rotunda Hospital, Dublin, Ireland.
² Department of Obstetrics and Gynecology, University Hospital Galway, Galway, Ireland.
³ Department of Obstetrics and Gynecology, Assisted Reproductive Technologies, Acibadem Maslak Hospital, Istanbul, Turkey.
⁴ Nueva Granada Military University, Bogota, Colombia.
⁵ Unisanitas, Bogota, Colombia.
⁶ DY Patil University, Navi Mumbai, India.

Editorial

Edgar Mocanu et al. Int J Gynaecol Obstet. 2025 Jun.

. 2025 Jun;169(3):865-866.

doi: 10.1002/ijgo.70138. Epub 2025 Apr 12.

¹ Department of Obstetrics and Gynecology, Rotunda Hospital, Dublin, Ireland.
² Department of Obstetrics and Gynecology, University Hospital Galway, Galway, Ireland.
³ Department of Obstetrics and Gynecology, Assisted Reproductive Technologies, Acibadem Maslak Hospital, Istanbul, Turkey.
⁴ Nueva Granada Military University, Bogota, Colombia.
⁵ Unisanitas, Bogota, Colombia.
⁶ DY Patil University, Navi Mumbai, India.

No abstract available

References

1. Woodruff TK. Oncofertility: a grand collaboration between reproductive medicine and oncology. Reproduction. 2015;150:S1‐S10.
1. Rashedi AS, de Roo SF, Ataman LM. Survey of fertility preservation options available to patients with cancer around the globe. JCO Glob Oncol. 2020;6:JGO.2016.008144.
1. Ozimek N, Salama M, Woodruff TK. National oncofertility registries around the globe: a pilot study. Front Endocrinol Lausanne. 2023;14:1148314.
1. Oktay K, Harvey BE, Loren AW. Fertility preservation in patients with cancer: ASCO practice guideline update summary. J Oncol Pract. 2018;14:381‐385.
1. Feldberg D, Purandare N. Cancer therapy and reproductive impact. Int J Gynecol Obstet. 2025;169:891‐894.